Diabetes incidence and prevalence in Hong Kong, China during 2006-2014 - PubMed (original) (raw)
. 2017 Jul;34(7):902-908.
doi: 10.1111/dme.13284. Epub 2016 Nov 29.
Affiliations
- PMID: 27859570
- DOI: 10.1111/dme.13284
Diabetes incidence and prevalence in Hong Kong, China during 2006-2014
J Quan et al. Diabet Med. 2017 Jul.
Abstract
Aims: To estimate recent secular changes in the incidence and prevalence of diabetes and pre-diabetes among Hong Kong Chinese adults, and thus show possible future trends for developing mainland China.
Methods: Based on a complete census of the public sector health records of 6.4 million people from 2006 to 2014, diabetes cases were ascertained using different methods including the World Health Organization (WHO) 2011 guidelines (HbA1c , fasting plasma glucose and glucose tolerance test), American Diabetes Association (ADA) 2015 guidelines (plus random plasma glucose), and additionally recorded diagnosis codes and medication dispensation. Pre-diabetes was defined using ADA 2015 guidelines.
Results: We identified 697 201 people with diabetes (54.2% were incident cases); and 1 229 731 people with diabetes or pre-diabetes. In 2014, the overall incidence of diabetes was 9.46 per 1000 person-years [95% confidence interval (CI): 9.38 to 9.54], and overall prevalence was 10.29% (95% CI: 10.27% to 10.32%). Incidence of diabetes decreased significantly from 2007 to 2014 (quadratic trend, P < 0.001). From 2006 to 2014, the prevalence of diabetes increased significantly in both sexes and across all age groups (quadratic trend, P < 0.001). The overall incidence of pre-diabetes in 2014 was 18.88 per 1000 person-years (95% CI: 18.76 to 18.99), and the overall prevalence of pre-diabetes was 8.90% (95% CI: 8.87% to 8.92%).
Conclusions: Similar to other developed western and Asian populations, diabetes (and pre-diabetes) incidence in Hong Kong Chinese appeared to have stabilized and there have been small declines during the period of observation. Ageing and survivorship will likely drive a continued increase in the prevalence of diabetes and pre-diabetes, albeit with a decelerating growth rate if past trends persist.
© 2016 Diabetes UK.
Similar articles
- Secular trends in incidence of type 1 and type 2 diabetes in Hong Kong: A retrospective cohort study.
Luk AOY, Ke C, Lau ESH, Wu H, Goggins W, Ma RCW, Chow E, Kong APS, So WY, Chan JCN. Luk AOY, et al. PLoS Med. 2020 Feb 20;17(2):e1003052. doi: 10.1371/journal.pmed.1003052. eCollection 2020 Feb. PLoS Med. 2020. PMID: 32078650 Free PMC article. - Diagnostic efficiency of hemoglobin A1c for newly diagnosed diabetes and prediabetes in community-based Chinese adults aged 40 years or older.
Liang K, Sun Y, Li WJ, Zhang XP, Li CQ, Yang WF, Ma ZQ, Ma AX, Zheng HZ, Song J, Lin P, Hou XG, Chen L. Liang K, et al. Diabetes Technol Ther. 2014 Dec;16(12):853-7. doi: 10.1089/dia.2014.0157. Epub 2014 Jul 11. Diabetes Technol Ther. 2014. PMID: 25014878 Free PMC article. - Prevalence of Prediabetes Among Adolescents and Young Adults in the United States, 2005-2016.
Andes LJ, Cheng YJ, Rolka DB, Gregg EW, Imperatore G. Andes LJ, et al. JAMA Pediatr. 2020 Feb 1;174(2):e194498. doi: 10.1001/jamapediatrics.2019.4498. Epub 2020 Feb 3. JAMA Pediatr. 2020. PMID: 31790544 Free PMC article. - Prevalence of Pre-Diabetes across Ethnicities: A Review of Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT) for Classification of Dysglycaemia.
Yip WCY, Sequeira IR, Plank LD, Poppitt SD. Yip WCY, et al. Nutrients. 2017 Nov 22;9(11):1273. doi: 10.3390/nu9111273. Nutrients. 2017. PMID: 29165385 Free PMC article. Review. - Prevalence of type 2 diabetes mellitus of Chinese populations in Mainland China, Hong Kong, and Taiwan.
Wong KC, Wang Z. Wong KC, et al. Diabetes Res Clin Pract. 2006 Aug;73(2):126-34. doi: 10.1016/j.diabres.2006.01.007. Epub 2006 Mar 24. Diabetes Res Clin Pract. 2006. PMID: 16563548 Review.
Cited by
- Clinical research progress on β-cell dysfunction in T2DM development in the Chinese population.
Chen Y, Jiang Q, Xing X, Yuan T, Li P. Chen Y, et al. Rev Endocr Metab Disord. 2024 Oct 9. doi: 10.1007/s11154-024-09914-9. Online ahead of print. Rev Endocr Metab Disord. 2024. PMID: 39382753 Review. - Prevalence and factors associated with diabetes-related distress in type 2 diabetes patients: a study in Hong Kong primary care setting.
Wong MH, Kwan SM, Dao MC, Fu SN, Luk W. Wong MH, et al. Sci Rep. 2024 May 9;14(1):10688. doi: 10.1038/s41598-024-61538-w. Sci Rep. 2024. PMID: 38724683 Free PMC article. - Outcomes of a risk assessment and management program using telecare consultation among patients with diabetes mellitus in general out-patient clinic: a hybrid effectiveness-implementation study protocol.
Wong AKC, Wong FKY, Liang J, Tong DWK, Chan ML, Chu TK, Wong BC, Chan RSY, Ho WH, Tang CYS, Chiang SC. Wong AKC, et al. Ann Med. 2023;55(2):2262088. doi: 10.1080/07853890.2023.2262088. Epub 2023 Sep 25. Ann Med. 2023. PMID: 37748120 Free PMC article. - Review on Monoclonal Antibodies (mAbs) as a Therapeutic Approach for Type 1 Diabetes.
Agarwal G, Patel M. Agarwal G, et al. Curr Diabetes Rev. 2024;20(7):e310823220578. doi: 10.2174/1573399820666230831153249. Curr Diabetes Rev. 2024. PMID: 37653635 Review. - Parity and incident type 2 diabetes in older Chinese women: Guangzhou Biobank Cohort Study.
Su H, Jiang C, Zhang W, Zhu F, Jin Y, Cheng K, Lam T, Xu L. Su H, et al. Sci Rep. 2023 Jun 12;13(1):9504. doi: 10.1038/s41598-023-36786-x. Sci Rep. 2023. PMID: 37308533 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous